Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles

Expert Opinion on Drug Delivery

Volumn 7, Issue 5, 2010, Pages 565-575

  Ishihara, Tsutomu ^a   Mizushima, Tohru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Biodegradable particles; Drug encapsulation; Drug release behavior; PLA PLGA; Targeting

Indexed keywords

ANGIOPEPTIN; ARESTIN; ATRIDOX; BETAMETHASONE; BETAMETHASONE ACETATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE SODIUM PHOSPHATE; BETAMETHASONE VALERATE; BROMOCRIPTINE MESILATE; BUSERELIN ACETATE; DOXYCYCLINE; DRUG CARRIER; GENEXOL PM; GOSERELIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE SODIUM SUCCINATE; LEUPRORELIN; MACROGOL; MINOCYCLINE; NALTREXONE; NANOPARTICLE; OCTREOTIDE; PACLITAXEL; POLYGLACTIN; POLYLACTIC ACID; RISPERIDONE; SOMATULINE LA; SUPRECUR MP; TRIPTORELIN; UNCLASSIFIED DRUG; BIOMATERIAL; DELAYED RELEASE FORMULATION; DRUG;

BIODEGRADABILITY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; HYDROPHOBICITY; MOLECULAR INTERACTION; REVIEW; CHEMISTRY; DELAYED RELEASE FORMULATION; HUMAN;

BIOCOMPATIBLE MATERIALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 77951442506     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425241003713486     Document Type: Review

References (91)

1. Bajorath J. Integration of virtual and high-throughput screening. Nat Rev Drug Discov 2002;1:882-894 (Pubitemid 37361583)
2. Hefti FF. Requirements for a lead compound to become a clinical candidate. BMC Neurosci 2008;9(Suppl 3):S7
3. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005;19:311-330 (Pubitemid 40316520)
4. Marcato PD, Durán N. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol 2008;8:2216-2229
5. Langer R. Drug delivery and targeting. Nature 1998;392:5-10 (Pubitemid 28215187)
6. Yamaguchi T, Mizushima Y. Lipid microspheres for drug delivery from the pharmaceutical viewpoint. Crit Rev Ther Drug Carrier Syst 1994;11:215-229
7. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297-305 (Pubitemid 47554274)
8. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-2490
9. Okada H, Toguchi H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst 1995;12:1-99
10. Jain R, Shah NH, Malick AW, Rhodes CT. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev Ind Pharm 1998;24:703-727 (Pubitemid 28346446)
11. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283-318
12. Jalil R, Nixon JR. Biodegradable poly (lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul 1990;7:297-325
13. Garlotta D. A literature review of poly(Lactic Acid). J Poly Environ 2001;9:63-84
14. Singh S, Ray SS. Polylactide based nanostructured biomaterials and their applications. J Nanosci Nanotechnol 2007;7:2596-2615
15. Mundargi RC, Babu VR, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly (D,L-lactide-co-glycolide) and its derivatives. J Control Release 2008;125:193-209
16. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008;364:298-327
17. D'Souza SS, Faraj JA, DeLuca PP. A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech 2005;6:E553-64
18. Chaubal M. Polylactides/ glycolides--excipients for injectable drug. Drug Deliv Technol 2002;2:34-36
19. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-782
20. Kim SC, Kim DW, Shim YH, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 2001;72:191-202
21. Al-Tahami K, Singh J. Smart polymer based delivery systems for peptides and proteins. Recent Patents Drug Deliv Formulation 2007;1:65-71
22. Kempe S, Metz H, Mäder K. Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process. J Control Release 2008;130:220-225
23. Yu LX, Amidon GL, Polli JE, et al. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res 2002;19:921-925
24. Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv 2007;4:403-416
25. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173-182
26. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives Pharm Res 2007;24:1-16
27. Lassalle V, Ferreira ML. PLA nano-and microparticles for drug delivery: an overview of the methods of preparation. Macromol Biosci 2007;7:767-783
28. Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Edn 2006;17:247-289
29. Rangel-Yagui CO, Pessoa A Jr, Tavares LC. Micellar solubilization of drugs. J Pharm Pharm Sci 2005;8:147-165
30. Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res 1996;13:163-167 (Pubitemid 26076314)
31. Jones M, Leroux J. Polymeric micelles-a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48:101-111 (Pubitemid 29401986)
32. Attwood D, Florence AT. Surfactant systems, their chemistry, pharmacy and biology, London: Chapman and Hall Ltd; 1983
33. Ishihara T, Takahashi M, Higaki M, Mizushima Y. Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticles. Int J Pharm 2009;365:200-205
34. Ishihara T, Goto M, Kanazawa H, et al. Efficient entrapment of poorly water-soluble pharmaceuticals in hybrid nanoparticles. J Pharm Sci 2009;98:2357-2363
35. Yamamoto T, Yokoyama M, Opanasopit P, et al. What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core. J Control Release 2007;123:11-18
36. Letchford K, Liggins R, Burt H. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. J Pharm Sci 2008;97:1179-1190
37. Nagarajan R, Barry M, Ruckenstein E. Unusual selectivity in solubilization by block copolymer micelles. Langmuir 1986;2:210-215
38. Patel SK, Lavasanifar A, Choi P. Prediction of the solubility of cucurbitacin drugs in self-associating poly (ethylene oxide)-b-poly(alpha-benzyl carboxylate epsilon-caprolactone) block copolymer with different tacticities using molecular dynamics simulation. Biomaterials 2010;31:345-357
39. Patel S, Lavasanifar A, Choi P. Application of molecular dynamics simulation to predict the compatability between water-insoluble drugs and self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymers. Biomacromolecules 2008;9:3014-3023
40. Barrera DA, Zylstra E, Lansbury PT Jr, et al. Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine). J Am Chem Soc 1993;115:11010-11011
41. Trimaille T, Mondon K, Gurny R, Moller M. Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides). Int J Pharm 2006;319:147-154
42. Yokoyama M, Satoh A, Sakurai Y, et al. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 1998;55:219-229 (Pubitemid 28477613)
43. Lavasanifar A, Samuel J, Sattari S, Kwon GS. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm Res 2002;19:418-422
44. Torchilin VP. Lipid-core micelles for targeted drug delivery. Curr Drug Deliv 2005;2:319-327
45. Krishnadas A, Rubinstein I, Onyüksel H. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res 2003;20:297-302
46. Puri S, Kallinteri P, Higgins S, et al. Drug incorporation and release of water soluble drugs from novel functionalized poly(glycerol adipate) nanoparticles. J Control Release 2008;125:59-67
47. Govender T, Stolnik S, Garnett MC, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57:171-185
48. Bodmeier R, McGinity JW. The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Pharm Res 1987;4:465-471
49. Yamagata Y, Misaki M, Kurokawa T, et al. Preparation of a copoly (dl-lactic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone. Int J Pharm 2003;251:133-141
50. Lam XM, Duenas ET, Cleland JL. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J Pharm Sci 2001;90:1356-1365
51. Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J Control Release 2000;65:261-269
52. Croy SR, Kwon GS. Polymeric micelles for drug delivery. Curr Pharm Des 2006;12:4669-4684
53. Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 2001;70:63-70
54. Zhang X, Li Y, Chen X, et al. Synthesis and characterization of the paclitaxel/ MPEG-PLA block copolymer conjugate. Biomaterials 2005;26:2121-2128 (Pubitemid 39575355)
55. Hans ML, Maxwell C, Ehrlichman RS, et al. Evaluation of in vitro release and in vivo efficacy of mPEG-PLA-haloperidol conjugate micelle-like structures. J Biomed Mater Res B Appl Biomater. 2007;83:422-430
56. Bae Y, Nishiyama N, Fukushima S, et al. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005;16:122-130
57. Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res 2004;27:1-12
58. Boury F, Marchais H, Proust JE, Benoit JP. Bovine serum albumin release from poly(alpha-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties J Control Release 1997;45:75-86
59. Midoux P, Breuzard G, Gomez JP, Pichon C. Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Curr Gene Ther 2008;8:335-352
60. Hughes JA, Rao GA. Targeted polymers for gene delivery. Expert Opin Drug Deliv 2005;2:145-157
61. Yokoyama M, Inoue S, Kataoka K, et al. Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. A new type of polymeric anticancer agent. Makromol Chem Rapid Commun 1987;8:431-435
62. Yokoyama M, Okano T, Sakurai Y, et al. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Target 1999;7:171-186
63. Lee J, Cho EC, Cho K. Incorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene oxide) micelles. J Control Release 2004;94:323-335
64. Johansen P, Men Y, Audran R, et al. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res 1998;15:1103-1110
65. Huh KM, Lee SC, Cho YW, et al. Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 2005;101:59-68
66. Yokoyama M, Okano T, Sakurai Y, et al. Introduction of cisplatin into polymeric micelle. J Control Release 1996;39:351-356
67. Horisawa E, Hirota T, Kawazoe S, et al. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm Res 2002;19:403-410
68. Walter E, Dreher D, Kok M, et al. Hydrophilic poly(lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Release 2001;76:149-168
69. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010;385:113-142
70. Discher BM, Won YY, Ege DS, et al. Polymersomes: tough vesicles made from diblock copolymers. Science 1999;284:1143-1146
71. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20
72. Miyajima M, Koshika A, Okada J, et al. The effects of drug physico-chemical properties on release from copoly (lactic/glycolic acid) matrix. Int J Pharm 1998;169:255-263
73. Klose D, Siepmann F, Elkharraz K, Siepmann J. PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int J Pharm 2008;354:95-103
74. Menei P, Daniel V, Montero-Menei C, et al. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 1993;14:470-478
75. Fredenberg S, Reslow M, Axelsson A. Encapsulated zinc salt increases the diffusion of protein through PLG films. Int J Pharm 2009;370:47-53
76. Lam XM, Duenas ET, Daugherty AL, et al. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J Control Release 2000;67:281-292
77. Zhang Y, Zale S, Sawyer L, Bernstein H. Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis. J Biomed Mater Res 1997;34:531-538
78. Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat Biotechnol 2000;18:52-57
79. Tracy MA, Ward KL, Firouzabadian L, et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 1999;20:1057-1062
80. Kang N, Perron ME, Prud'homme RE, et al. Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability. Nano Lett 2005;5:315-319
81. Miyata K, Kakizawa Y, Nishiyama N, et al. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc 2004;126:2355-2361
82. Dong Y, Feng SS. Nanoparticles of poly (D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel. J Biomed Mater Res A 2006;78:12-19
83. Lee SW, Chang DH, Shim MS, et al. Ionically fixed polymeric nanoparticles as a novel drug carrier. Pharm Res 2007;24:1508-1516
84. Ashok B, Arleth L, Hjelm RP, et al. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci 2004;93:2476-2487 (Pubitemid 39319431)
85. Ghassemi AH, van Steenbergen MJ, Talsma H, et al. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J Control Release 2009;138:57-63
86. Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science 1994;263:1600-1603
87. Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-284
88. Ishihara T, Takahashi M, Higaki M, et al. Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles. Pharm Res 2008;25:1686-1695
89. Ishihara T, Takahashi M, Higaki M, et al. Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents. Int J Pharm 2010;385:170-175
90. Ishihara T, Kubota T, Choi T, Higaki M. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate. J Pharmacol Exp Ther 2009;329:412-417
91. Matsuo Y, Ishihara T, Ishizaki J, et al. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol 2009;260:33-38